Dewpoint Therapeutics
Paul discovered the powerful synergy of molecular modeling and NMR spectroscopy as an undergraduate researcher at Pomona College and has spent much of his career working at this interface. Paul was awarded a Gates Cambridge Scholarship to study for a Ph.D. in Chemistry at the University of Cambridge, where he developed computational methods to determine structures and dynamic ensembles of proteins from sparse NMR datasets. Paul trained in protein biochemistry and NMR spectroscopy as a postdoctoral fellow at Columbia University and developed new physical models to study intrinsically disordered proteins with molecular dynamics computer simulations as a scientist at D.E. Shaw Research. Paul is currently an Assistant Professor of Chemistry at Dartmouth College, where his laboratory integrates simulations and experiments to understand how small molecules bind and inhibit disordered proteins and design novel inhibitors.
This person is not in the org chart
This person is not in any offices
Dewpoint Therapeutics
Dewpoint Therapeutics is the first company founded to apply the emerging discipline of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions has pathways that are regulated by condensates or arise from the dysfunction of condensates - including cancer, neurodegeneration, and metabolic disease.